Lactational mastitis is an infection of one or more lobules of the mammary gland, occurring up to 33% of lactating mothers. Although the condition may happen at any point during the lactation period, between 75-95% of cases occur within the first 12 weeks, with the frequency particularly higher during the second and third weeks postpartum.
New research shows that lactational mastitis is a dysbiotic process. Significant levels of beneficial microbes including Lactobacillus gasseri and L. salivarius are found in healthy breastfeeding mothers, whilst their presence is unidentifiable in the milk of those with lactational mastitis. In comparison, high levels of pathogenic Staphylococcus aureus and S. epidermis are found in acute and chronic episodes of the disease respectively. Both strains display multi-drug resistance to antibiotics, explaining why this condition is difficult to treat and can become recurrent or chronic.
In this interview, Andrew interviews Belinda Reynolds, a noted dietitian with a special interest in women's health, pregnancy and breastfeeding. By explaining this truly groundbreaking research, Belinda highlights the potential that probiotic therapy has for the prevention and treatment of infectious lactational mastitis.
Belinda Reynolds is a dietitian andEducation Manager at BioCeuticals. She graduated with an Honours Degree in Nutrition and Dietetics, and has been involved in the complementary medicine industry for over 15 years. Her key interests are immune modulation, the human microbiome and the impact they have on overall health.
Other podcasts with Belinda include:
- Depression and Anxiety: Treating the Causes
- Extemporaneous Dispensing: The Clinical use of Calcium-D-Glucarate
- Extemporaneous Dispensing: The Clinical use of N-acetyl-cysteine
- Mythbusting Lactate-Producing Probiotics